VERA CHARITES Launches Five-Product IMMORA Line on November 2
JTARC Inc. renewed all products of its skincare brand VERA CHARITES and will launch five items under a new line, IMMORA Line, on November 2, 2026. The line pairs MX-N hyaluronic acid with spicules in every product.
1 source 4h ago
Reporting from 1 source: ASCII.jp.
Why it matters
The renewal places the same formulation claim, MX-N hyaluronic acid plus spicules, in every product in the lineup rather than in one item, ahead of the Taiwan and Hong Kong rollout in January 2027.
Key Facts
- JTARC Inc. will launch five products under its new IMMORA Line for the VERA CHARITES brand on November 2, 2026.
- In Japan the products sell at the official online store and at partner salons.
- Sales in Taiwan and Hong Kong are scheduled for January 2027 with locally tailored packaging.
- The line combines MX-N hyaluronic acid, processed into particles of roughly 20 nm, with spicules in every product.
- Research related to MX-N hyaluronic acid was presented at the 2026 congress of the International Federation of Societies of Cosmetic Chemists.
Two serums, Luminous Serum and Calm Serum, can be chosen by skin condition that day or layered. In Japan the products sell through the official online store and partner salons; Taiwan and Hong Kong follow in January 2027 with locally tailored packaging.
Spicules, the needle-shaped ingredient derived from sponge, go into every product from cleanser to cream, in a balance VERA CHARITES calls Minimum Effective Spicule Design. The company describes the resulting texture as having little tingling sensation and notes that individual experiences vary.
The other half of the formulation is MX-N hyaluronic acid, hyaluronic acid bound to magnesium and calcium and processed under high pressure into particles of roughly 20 nm. Research related to it was presented at the 2026 congress of the International Federation of Societies of Cosmetic Chemists. Packaging is white, with a wave motif and a silver logo.
Written with AI by Yomimono from the 1 cited source below, including Japanese-language reporting where cited. See our editorial policy.
Add Yomimono as a preferred source on Google